Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
Sonrotoclax (BGB-11417)
Sonrotoclax (BGB-11417) is a second-generation BCL-2 inhibitor with higher potency than the first-generation BCL-2 inhibitor Venetoclax (ABT-199. Our Product No: CT-A199). Exhibits strong in vitro and in vivo inhibitory activity against both WT Bcl-2 and the Venetoclax-resistant mutants, as well as excellent selectivity over BCL-XL without obvious cytochrome P450 inhibition (refs 1, 2). Sonrotoclax is being studied in combination with Zanubrutinib (Our Prod. NO. CT-ZANU) for chronic lymphocytic leukemia (CLL) and other cancers.
Catalog NO: CT-BGB11417
Synonym: BGB-11417
CAS NO: 2383086-06-2
Mol. Formula: C49H59N7O7S
MW: 890.1 (or refer to the Certificate of Analysis, batch-specific)
** in vivo Quality Material. >99% Pure by Achiral and Chiral HPLCs (attached). Hemihydrate, verified by a spot-on Elemental Anlysis. Bulk stock (Discounted price for 0.2, 0.5, 1G, …). Same Day Shipping.